Do not give TAKHZYRO to other people, even if they have the same symptoms that you have. Do not use TAKHZYRO for a condition for which it is not prescribed. Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. General information about the safe and effective use of TAKHZYRO. You may report side effects to FDA at 1-80. For more information, ask your healthcare provider or pharmacist.Ĭall your doctor for medical advice about side effects. These are not all the possible side effects of TAKHZYRO. Tell your healthcare provider if you have any side effect that bothers you or that does not go away. Call your healthcare provider or get emergency help right away if you have any of the following symptoms: Allergic reactions may happen with TAKHZYRO. TAKHZYRO may cause serious side effects, including allergic reactions. What are the possible side effects of TAKHZYRO?
Copays copay relief how to#
Your healthcare provider should show you or your caregiver how to prepare and inject your dose of TAKHZYRO before you inject yourself for the first time.
Copays copay relief skin#
TAKHZYRO is given as an injection under your skin (subcutaneous) by you or a caregiver.Use TAKHZYRO exactly as your healthcare provider tells you to use it.See the detailed Instructions for Use that comes with this patient information leaflet about the right way to prepare and inject TAKHZYRO. Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, or herbal supplements. Talk to your healthcare provider about the best way to feed your baby while using TAKHZYRO. It is not known if TAKHZYRO passes into your breastmilk. It is not known if TAKHZYRO can harm your unborn baby.Īre breastfeeding or plan to breastfeed. are pregnant or planning to become pregnant.It is not known if TAKHZYRO is safe and effective in children under 2 years of age.īefore you use TAKHZYRO, tell your healthcare provider about all of your medical conditions, including if you: TAKHZYRO is a prescription medicine used to prevent attacks of Hereditary Angioedema (HAE) in people 2 years of age and older. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment. Read this Patient Information before you start using TAKHZYRO and each time you get a refill. TAKHZYRO ® (tak-ZYE-roe) (lanadelumab-flyo) injection, for subcutaneous use Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. If your insurance situation changes you must notify the Program immediately at 1-86. Void where use is prohibited by your insurance provider. This does not constitute health insurance. territories, and does not apply where prohibited by law, taxed, or restricted.
The Program only applies in the United States, including Puerto Rico and other U.S. Copayment assistance under the Program is not transferable.
Copays copay relief free#
The Program cannot be combined with any other rebate/coupon, free trial, or similar offer.
No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third party payer, whether public or private. IMPORTANT NOTICE: The OnePath Copay Assistance Program (the Program) is not valid for prescriptions eligible to be reimbursed, in whole or in part, by Medicaid, Medicare (including Medicare Part D), Tricare, Medigap, VA, DoD, or other federal or state programs (including any medical or state prescription drug assistance programs).
0 kommentar(er)
